Peep Palumaa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Peep Palumaa has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Rannar Sillard
Department of Gene Technology, Tallinn Technical University, Akadeemia tee 15, 12618 Tallinn, Estonia
5 shared publicationsHans Jörnvall
3 shared publicationsLiina Kangur
3 shared publicationsAnastassia Voronova
Department of Gene Technology, Tallinn Technical University, Akadeemia tee 15, 12618 Tallinn, Estonia
2 shared publications- Andra Noormägi
Department of Gene Technology, Tallinn University of Technology, Tallinn 12618, Estonia
2 shared publications Elo Eriste
Karolinska Institutet
2 shared publications
Latest Publications
- 14 November 2011
- Published by Wiley in Journal of Peptide Science
- Vol. 18 (1) , 59-64
Interference of low‐molecular substances with the thioflavin‐T fluorescence assay of amyloid fibrils
Abnormal fibrillization of amyloidogenic peptides/proteins has been linked to various neurodegenerative diseases such as Alzheimer's and Parkinson's disease as well as with type‐II diabetes mellitus. The kinetics of protein fibrillization is commonly studied by using a fluorescent dye Thioflavin T (ThT) that binds to protein fibrils and exerts increased fluorescence intensity in bound state. Recently, it has been demonstrated that several low‐molecular weight compounds like Basic Blue 41, Basic Blue 12, Azure C, and Tannic acid interfere with the fluorescence of ThT bound to Alzheimers' amyloid‐β fibrils and cause false positive results during the screening of fibrillization inhibitors. In the current study, we demonstrated that the same selected substances also decrease the fluorescence signal of ThT bound to insulin fibrils already at submicromolar or micromolar concentrations. Kinetic experiments show that unlike to true inhibitors, these compounds did neither decrease the fibrillization rate nor increase the lag‐period. Absence of soluble insulin in the end of the experiment confirmed that these compounds do not disaggregate the insulin fibrils and, thus, are not fibrillization inhibitors at concentrations studied. Our results show that interference with ThT test is a general phenomenon and more attention has to be paid to interpretation of kinetic results of protein fibrillization obtained by using fluorescent dyes. Copyright © 2011 European Peptide Society and John Wiley & Sons, Ltd.
- 14 November 2011
- Published by Wiley in Journal of Peptide Science
- Vol. 18 (1) , 59-64
Interference of low‐molecular substances with the thioflavin‐T fluorescence assay of amyloid fibrils
Abnormal fibrillization of amyloidogenic peptides/proteins has been linked to various neurodegenerative diseases such as Alzheimer's and Parkinson's disease as well as with type‐II diabetes mellitus. The kinetics of protein fibrillization is commonly studied by using a fluorescent dye Thioflavin T (ThT) that binds to protein fibrils and exerts increased fluorescence intensity in bound state. Recently, it has been demonstrated that several low‐molecular weight compounds like Basic Blue 41, Basic Blue 12, Azure C, and Tannic acid interfere with the fluorescence of ThT bound to Alzheimers' amyloid‐β fibrils and cause false positive results during the screening of fibrillization inhibitors. In the current study, we demonstrated that the same selected substances also decrease the fluorescence signal of ThT bound to insulin fibrils already at submicromolar or micromolar concentrations. Kinetic experiments show that unlike to true inhibitors, these compounds did neither decrease the fibrillization rate nor increase the lag‐period. Absence of soluble insulin in the end of the experiment confirmed that these compounds do not disaggregate the insulin fibrils and, thus, are not fibrillization inhibitors at concentrations studied. Our results show that interference with ThT test is a general phenomenon and more attention has to be paid to interpretation of kinetic results of protein fibrillization obtained by using fluorescent dyes. Copyright © 2011 European Peptide Society and John Wiley & Sons, Ltd.
- 27 August 2010
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 430 (3) , 511-518
Zn(II) ions co-secreted with insulin suppress inherent amyloidogenic properties of monomeric insulin
Insulin, a 51-residue peptide hormone, is an intrinsically amyloidogenic peptide, forming amyloid fibrils in vitro. In the secretory granules, insulin is densely packed together with Zn(II) into crystals of Zn2Insulin6 hexamer, which assures osmotic stability of vesicles and prevents fibrillation of the peptide. However, after release from the pancreatic β-cells, insulin dissociates into active monomers, which tend to fibrillize not only at acidic, but also at physiological, pH values. The effect of co-secreted Zn(II) ions on the fibrillation of monomeric insulin is unknown, however, it might prevent insulin fibrillation. We showed that Zn(II) inhibits fibrillation of monomeric insulin at physiological pH values by forming a soluble Zn(II)–insulin complex. The inhibitory effect of Zn(II) ions is very strong at pH 7.3 (IC50=3.5 μM), whereas at pH 5.5 it progressively weakens, pointing towards participation of the histidine residue(s) in complex formation. The results obtained indicate that Zn(II) ions might suppress fibrillation of insulin at its release sites and in circulation. It is hypothesized that misfolded oligomeric intermediates occurring in the insulin fibrillation pathway, especially in zinc-deficient conditions, might induce autoantibodies against insulin, which leads to β-cell damage and autoimmune Type 1 diabetes.
- 27 August 2010
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 430 (3) , 511-518
Zn(II) ions co-secreted with insulin suppress inherent amyloidogenic properties of monomeric insulin
Insulin, a 51-residue peptide hormone, is an intrinsically amyloidogenic peptide, forming amyloid fibrils in vitro. In the secretory granules, insulin is densely packed together with Zn(II) into crystals of Zn2Insulin6 hexamer, which assures osmotic stability of vesicles and prevents fibrillation of the peptide. However, after release from the pancreatic β-cells, insulin dissociates into active monomers, which tend to fibrillize not only at acidic, but also at physiological, pH values. The effect of co-secreted Zn(II) ions on the fibrillation of monomeric insulin is unknown, however, it might prevent insulin fibrillation. We showed that Zn(II) inhibits fibrillation of monomeric insulin at physiological pH values by forming a soluble Zn(II)–insulin complex. The inhibitory effect of Zn(II) ions is very strong at pH 7.3 (IC50=3.5 μM), whereas at pH 5.5 it progressively weakens, pointing towards participation of the histidine residue(s) in complex formation. The results obtained indicate that Zn(II) ions might suppress fibrillation of insulin at its release sites and in circulation. It is hypothesized that misfolded oligomeric intermediates occurring in the insulin fibrillation pathway, especially in zinc-deficient conditions, might induce autoantibodies against insulin, which leads to β-cell damage and autoimmune Type 1 diabetes.
- 1 May 2009
- Published by SAGE Publications in Antioxidants & Redox Signaling
- Vol. 11 (5) , 985-995
Modulation of Redox Switches of Copper Chaperone Cox17 by Zn(II) Ions Determined by New ESI MS-Based Approach
Cox17, a copper chaperone for cytochrome-c oxidase, contains six conserved Cys residues and exists in three oxidative states, linked with two thiol-based redox switches. The first switch leads to formation of two disulfides and occurs upon transport of Cox17 into mitochondrial intermembrane space (IMS). Cox172S-S is retained in the IMS and is also a functional form of the protein, which can be further oxidized to Cox173S-S. According to the midpoint redox potential values, Cox17 can be partially oxidized in the cytosol, which might hinder its transport into IMS. We hypothesize that Zn(II) ions might protect cytosolic Cox17 from oxidation. In order to get quantitative information about the modulatory effect of Zn(II) ions on redox switches in Cox17, we have used ESI MS for determination of the midpoint potentials for redox couples of Cox17: Cox173S-S ↔ Cox172S-S (Em1) and Cox172S-S ↔ Cox170S-S (Em2) in the presence of Zn(II). 10 μM Zn(II) ions shift the Em2 by 21 mV and Em1 by 15 mV to more positive values. Apparent dissociation constants for Zn(II) complexes of Cox170S-S and Cox172S-S, are 0.067 and 0.29 nM, respectively. The high affinity shows that metallation of Cox170S-S by Zn(II) might be significant in cellular conditions, which might protect Cox17 from oxidation and enable its transport into IMS. Antioxid. Redox Signal. 11, 985–995.
- 1 May 2009
- Published by SAGE Publications in Antioxidants & Redox Signaling
- Vol. 11 (5) , 985-995
Modulation of Redox Switches of Copper Chaperone Cox17 by Zn(II) Ions Determined by New ESI MS-Based Approach
Cox17, a copper chaperone for cytochrome-c oxidase, contains six conserved Cys residues and exists in three oxidative states, linked with two thiol-based redox switches. The first switch leads to formation of two disulfides and occurs upon transport of Cox17 into mitochondrial intermembrane space (IMS). Cox172S-S is retained in the IMS and is also a functional form of the protein, which can be further oxidized to Cox173S-S. According to the midpoint redox potential values, Cox17 can be partially oxidized in the cytosol, which might hinder its transport into IMS. We hypothesize that Zn(II) ions might protect cytosolic Cox17 from oxidation. In order to get quantitative information about the modulatory effect of Zn(II) ions on redox switches in Cox17, we have used ESI MS for determination of the midpoint potentials for redox couples of Cox17: Cox173S-S ↔ Cox172S-S (Em1) and Cox172S-S ↔ Cox170S-S (Em2) in the presence of Zn(II). 10 μM Zn(II) ions shift the Em2 by 21 mV and Em1 by 15 mV to more positive values. Apparent dissociation constants for Zn(II) complexes of Cox170S-S and Cox172S-S, are 0.067 and 0.29 nM, respectively. The high affinity shows that metallation of Cox170S-S by Zn(II) might be significant in cellular conditions, which might protect Cox17 from oxidation and enable its transport into IMS. Antioxid. Redox Signal. 11, 985–995.
- 1 May 2009
- Published by SAGE Publications in Antioxidants & Redox Signaling
- Vol. 11 (5) , 981-983
Biological Redox Switches
Research over the last decade has substantially advanced our understanding of cellular redox chemistry and introduced new terms to redox signaling and biological redox switches. It emerges that redox switching affects a plethora of biological processes and seems to be necessary to counterbalance oxidative stress and guarantee cellular survival in oxidative conditions. Despite intensive studies, the mechanisms of redox switching and its consequences are poorly understood, which points towards an extremely complex nature of these phenomena. Indeed, in contrast to classical signalling cascades, cellular redox signaling seems to affect the whole cellular redox environment and a large number of different redox switches. A majority of biological redox switches rely on the oxidation of thiol group(s) of cysteine residue(s); however, thiolates also bind transition metal ions like Zn(II), Cu(I), and iron, and these metal-thiolate motifs also function as redox switches. It follows that a deeper understanding of redox signalling and redox switches could be achieved by a multidisciplinary approach combining advances in the redox chemistry of sulphur, the chemistry of reactive oxygen and nitrogen species, as well as the bioinorganic chemistry of metal complexes. Many of these aspects are reviewed in the current forum issue on biological redox switches with the aim to promote the understanding of cellular redox phenomena at system biology level. Antioxid. Redox Signal. 11, 981–983.
- 1 May 2009
- Published by SAGE Publications in Antioxidants & Redox Signaling
- Vol. 11 (5) , 981-983
Biological Redox Switches
Research over the last decade has substantially advanced our understanding of cellular redox chemistry and introduced new terms to redox signaling and biological redox switches. It emerges that redox switching affects a plethora of biological processes and seems to be necessary to counterbalance oxidative stress and guarantee cellular survival in oxidative conditions. Despite intensive studies, the mechanisms of redox switching and its consequences are poorly understood, which points towards an extremely complex nature of these phenomena. Indeed, in contrast to classical signalling cascades, cellular redox signaling seems to affect the whole cellular redox environment and a large number of different redox switches. A majority of biological redox switches rely on the oxidation of thiol group(s) of cysteine residue(s); however, thiolates also bind transition metal ions like Zn(II), Cu(I), and iron, and these metal-thiolate motifs also function as redox switches. It follows that a deeper understanding of redox signalling and redox switches could be achieved by a multidisciplinary approach combining advances in the redox chemistry of sulphur, the chemistry of reactive oxygen and nitrogen species, as well as the bioinorganic chemistry of metal complexes. Many of these aspects are reviewed in the current forum issue on biological redox switches with the aim to promote the understanding of cellular redox phenomena at system biology level. Antioxid. Redox Signal. 11, 981–983.
- 29 October 2007
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 408 (1) , 139-148
Oxidative switches in functioning of mammalian copper chaperone Cox17
Cox17, a copper chaperone for cytochrome-c oxidase, is an essential and highly conserved protein in eukaryotic organisms. Yeast and mammalian Cox17 share six conserved cysteine residues, which are involved in complex redox reactions as well as in metal binding and transfer. Mammalian Cox17 exists in three oxidative states, each characterized by distinct metal-binding properties: fully reduced mammalian Cox170S–S binds co-operatively to four Cu+; Cox172S–S, with two disulfide bridges, binds to one of either Cu+ or Zn2+; and Cox173S–S, with three disulfide bridges, does not bind to any metal ions. The Em (midpoint redox potential) values for two redox couples of Cox17, Cox173S–S↔Cox172S–S (Em1) and Cox172S–S↔Cox170S–S (Em2), were determined to be −197 mV and −340 mV respectively. The data indicate that an equilibrium exists in the cytosol between Cox170S-S and Cox172S–S, which is slightly shifted towards Cox170S-S. In the IMS (mitochondrial intermembrane space), the equilibrium is shifted towards Cox172S–S, enabling retention of Cox172S–S in the IMS and leading to the formation of a biologically competent form of the Cox17 protein, Cox172S–S, capable of copper transfer to the copper chaperone Sco1. XAS (X-ray absorption spectroscopy) determined that Cu4Cox17 contains a Cu4S6-type copper–thiolate cluster, which may provide safe storage of an excess of copper ions.
- 29 October 2007
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 408 (1) , 139-148
Oxidative switches in functioning of mammalian copper chaperone Cox17
Cox17, a copper chaperone for cytochrome-c oxidase, is an essential and highly conserved protein in eukaryotic organisms. Yeast and mammalian Cox17 share six conserved cysteine residues, which are involved in complex redox reactions as well as in metal binding and transfer. Mammalian Cox17 exists in three oxidative states, each characterized by distinct metal-binding properties: fully reduced mammalian Cox170S–S binds co-operatively to four Cu+; Cox172S–S, with two disulfide bridges, binds to one of either Cu+ or Zn2+; and Cox173S–S, with three disulfide bridges, does not bind to any metal ions. The Em (midpoint redox potential) values for two redox couples of Cox17, Cox173S–S↔Cox172S–S (Em1) and Cox172S–S↔Cox170S–S (Em2), were determined to be −197 mV and −340 mV respectively. The data indicate that an equilibrium exists in the cytosol between Cox170S-S and Cox172S–S, which is slightly shifted towards Cox170S-S. In the IMS (mitochondrial intermembrane space), the equilibrium is shifted towards Cox172S–S, enabling retention of Cox172S–S in the IMS and leading to the formation of a biologically competent form of the Cox17 protein, Cox172S–S, capable of copper transfer to the copper chaperone Sco1. XAS (X-ray absorption spectroscopy) determined that Cu4Cox17 contains a Cu4S6-type copper–thiolate cluster, which may provide safe storage of an excess of copper ions.
- 1 March 2005
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1747 (2) , 205-211
Metal binding of metallothionein-3 versus metallothionein-2: lower affinity and higher plasticity
- 1 March 2005
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1747 (2) , 205-211
Metal binding of metallothionein-3 versus metallothionein-2: lower affinity and higher plasticity
- 10 August 2004
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 382 (1) , 307-314
Metal-binding mechanism of Cox17, a copper chaperone for cytochrome c oxidase
Cox17, a copper chaperone for cytochrome c oxidase, is an essential and highly conserved protein. The structure and mechanism of functioning of Cox17 are unknown, and even its metalbinding stoichiometry is elusive. In the present study, we demonstrate, using electrospray ionization–MS, that porcine Cox17 binds co-operatively four Cu+ ions. Cu4Cox17 is stable at pH values above 3 and fluorescence spectra indicate the presence of a solvent-shielded multinuclear Cu(I) cluster. Combining our results with earlier EXAFS results on yeast CuCox17, we suggest that Cu4Cox17 contains a Cu4S6-type cluster. At supramillimolar concentrations, dithiothreitol extracts metals from Cu4Cox17, and an apparent copper dissociation constant KCu=13 fM was calculated from these results. Charge-state distributions of different Cox17 forms suggest that binding of the first Cu+ ion to Cox17 causes a conformational change from an open to a compact state, which may be the rate-limiting step in the formation of Cu4Cox17. Cox17 binds non-co-operatively two Zn2+ ions, but does not bind Ag+ ions, which highlights its extremely high metal-binding specificity. We further demonstrate that porcine Cox17 can also exist in partly oxidized (two disulphide bridges) and fully oxidized (three disulphide bridges) forms. Partly oxidized Cox17 can bind one Cu+ or Zn2+ ion, whereas fully oxidized Cox17 does not bind metals. The metal-binding properties of Cox17 imply that, in contrast with other copper chaperones, Cox17 is designed for the simultaneous transfer of up to four copper ions to partner proteins. Metals can be released from Cox17 by non-oxidative as well as oxidative mechanisms.
- 10 August 2004
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 382 (1) , 307-314
Metal-binding mechanism of Cox17, a copper chaperone for cytochrome c oxidase
Cox17, a copper chaperone for cytochrome c oxidase, is an essential and highly conserved protein. The structure and mechanism of functioning of Cox17 are unknown, and even its metalbinding stoichiometry is elusive. In the present study, we demonstrate, using electrospray ionization–MS, that porcine Cox17 binds co-operatively four Cu+ ions. Cu4Cox17 is stable at pH values above 3 and fluorescence spectra indicate the presence of a solvent-shielded multinuclear Cu(I) cluster. Combining our results with earlier EXAFS results on yeast CuCox17, we suggest that Cu4Cox17 contains a Cu4S6-type cluster. At supramillimolar concentrations, dithiothreitol extracts metals from Cu4Cox17, and an apparent copper dissociation constant KCu=13 fM was calculated from these results. Charge-state distributions of different Cox17 forms suggest that binding of the first Cu+ ion to Cox17 causes a conformational change from an open to a compact state, which may be the rate-limiting step in the formation of Cu4Cox17. Cox17 binds non-co-operatively two Zn2+ ions, but does not bind Ag+ ions, which highlights its extremely high metal-binding specificity. We further demonstrate that porcine Cox17 can also exist in partly oxidized (two disulphide bridges) and fully oxidized (three disulphide bridges) forms. Partly oxidized Cox17 can bind one Cu+ or Zn2+ ion, whereas fully oxidized Cox17 does not bind metals. The metal-binding properties of Cox17 imply that, in contrast with other copper chaperones, Cox17 is designed for the simultaneous transfer of up to four copper ions to partner proteins. Metals can be released from Cox17 by non-oxidative as well as oxidative mechanisms.
- 14 August 2002
- Published by Wiley in FEBS Letters
- Vol. 527 (1-3) , 76-80
Evidence for non‐isostructural replacement of Zn2+ with Cd2+ in the β‐domain of brain‐specific metallothionein‐3
Metallothionein‐3 (MT‐3) is a brain‐specific MT, which is downregulated in Alzheimer's disease. The N‐terminal region of CdMT‐3 is highly dynamic and has escaped structural characterization by nuclear magnetic resonance. We have used electrospray ionization mass spectrometry to probe conformational states of cadmium‐ and zinc‐substituted metalloforms of MT‐3 and can demonstrate that the N‐terminal β‐domain of MT‐3 filled with Cd2+ has a more open conformation than that filled with Zn2+. The results suggest that the larger Cd2+ ions cannot isostructurally replace zinc in the β‐domain of MT‐3 whereas in the case of MT‐1 and MT‐2 the replacement is isostructural. Specific metal binding properties of the β‐domain of MT‐3 may be essential for fulfilling the specific role of MT‐3 in the brain.
- 14 August 2002
- Published by Wiley in FEBS Letters
- Vol. 527 (1-3) , 76-80
Evidence for non‐isostructural replacement of Zn2+ with Cd2+ in the β‐domain of brain‐specific metallothionein‐3
Metallothionein‐3 (MT‐3) is a brain‐specific MT, which is downregulated in Alzheimer's disease. The N‐terminal region of CdMT‐3 is highly dynamic and has escaped structural characterization by nuclear magnetic resonance. We have used electrospray ionization mass spectrometry to probe conformational states of cadmium‐ and zinc‐substituted metalloforms of MT‐3 and can demonstrate that the N‐terminal β‐domain of MT‐3 filled with Cd2+ has a more open conformation than that filled with Zn2+. The results suggest that the larger Cd2+ ions cannot isostructurally replace zinc in the β‐domain of MT‐3 whereas in the case of MT‐1 and MT‐2 the replacement is isostructural. Specific metal binding properties of the β‐domain of MT‐3 may be essential for fulfilling the specific role of MT‐3 in the brain.
- 20 April 2002
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 41 (19) , 6158-6163
Brain-Specific Metallothionein-3 Has Higher Metal-Binding Capacity than Ubiquitous Metallothioneins and Binds Metals Noncooperatively
Zinc metabolism in the cells is largely regulated by ubiquitous small proteins, metallothioneins (MT). Metallothionein-3 is specifically expressed in the brain and is down regulated in Alzheimer's disease. We demonstrate by mass spectrometry that MT-3, in contrast to common MTs, binds Zn2+ and Cd2+ in a noncooperative manner and can also bind higher stoichiometries of metals than seven. MT-3 reconstituted with seven metals exists in a dynamic equilibrium of different metalloforms, where the prevalent metalloform is Me7MT-3, but metalloforms with 6, 8, and even 9 metals are also present. The results from pH and stability studies demonstrate that the heterogeneity of metalloforms originates from the N-terminal β-cluster, whereas the C-terminal α-cluster of MT-3 binds four metal ions such as that of common MTs. Experiments with EDTA demonstrate that the β-cluster of ZnMT-3 has a higher metal transfer potential than the β-cluster of Zn7MT-2. Moreover, ZnMT-3 loses metals during ultrafiltration. MT-3, reconstituted with an excess of Zn2+ or Cd2+, exists as a dynamic mixture of metalloforms with higher than 7 metal stoichiometries (8−11). Such forms of ZnMT-3 are unstable and decompose partly already during a rapid gel filtration, whereas CdMT-3 forms are more stable. Extra metal ions may bind to the β-cluster region as well as to the carboxylates of MT-3. The specific metal-binding properties of MT-3 could be functionally implemented for buffering of fluctuating concentrations of zinc in zincergic neurons and for transfer of zinc to synaptic vesicles.
- 20 April 2002
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 41 (19) , 6158-6163
Brain-Specific Metallothionein-3 Has Higher Metal-Binding Capacity than Ubiquitous Metallothioneins and Binds Metals Noncooperatively
Zinc metabolism in the cells is largely regulated by ubiquitous small proteins, metallothioneins (MT). Metallothionein-3 is specifically expressed in the brain and is down regulated in Alzheimer's disease. We demonstrate by mass spectrometry that MT-3, in contrast to common MTs, binds Zn2+ and Cd2+ in a noncooperative manner and can also bind higher stoichiometries of metals than seven. MT-3 reconstituted with seven metals exists in a dynamic equilibrium of different metalloforms, where the prevalent metalloform is Me7MT-3, but metalloforms with 6, 8, and even 9 metals are also present. The results from pH and stability studies demonstrate that the heterogeneity of metalloforms originates from the N-terminal β-cluster, whereas the C-terminal α-cluster of MT-3 binds four metal ions such as that of common MTs. Experiments with EDTA demonstrate that the β-cluster of ZnMT-3 has a higher metal transfer potential than the β-cluster of Zn7MT-2. Moreover, ZnMT-3 loses metals during ultrafiltration. MT-3, reconstituted with an excess of Zn2+ or Cd2+, exists as a dynamic mixture of metalloforms with higher than 7 metal stoichiometries (8−11). Such forms of ZnMT-3 are unstable and decompose partly already during a rapid gel filtration, whereas CdMT-3 forms are more stable. Extra metal ions may bind to the β-cluster region as well as to the carboxylates of MT-3. The specific metal-binding properties of MT-3 could be functionally implemented for buffering of fluctuating concentrations of zinc in zincergic neurons and for transfer of zinc to synaptic vesicles.
- Open Access
- 1 September 2001
- Published by Wiley in European Journal of Biochemistry
- Vol. 268 (18) , 4979-4984
The effects of physiologically important nonmetallic ligands in the reactivity of metallothionein towards 5,5′-dithiobis(2-nitrobenzoic acid)
- 1 September 2001
- Published by Wiley in European Journal of Biochemistry
- Vol. 268 (18) , 4979-4984
Open AccessThe effects of physiologically important nonmetallic ligands in the reactivity of metallothionein towards 5,5′-dithiobis(2-nitrobenzoic acid)